228 related articles for article (PubMed ID: 3550177)
1. [Detection of antinuclear antibodies using HEp-2 cells as nuclear substrates by the indirect immunofluorescent antibody technic].
Watanabe S; Miyawaki S
Rinsho Byori; 1987 Jan; 35(1):61-6. PubMed ID: 3550177
[No Abstract] [Full Text] [Related]
2. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
[TBL] [Abstract][Full Text] [Related]
3. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
Uchida K; Kondo H; Kashiwazaki S
Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
[No Abstract] [Full Text] [Related]
4. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
[No Abstract] [Full Text] [Related]
5. [Anticentromere antibodies. Diagnostic and prognostic value].
Meyer O; Haïm T
Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of anticentromere antibody assay].
Moteki S
Nihon Rinsho; 1990 Feb; 48 Suppl():580-3. PubMed ID: 2192153
[No Abstract] [Full Text] [Related]
8. The clinical significance of the in vivo antinuclear antibody phenomenon.
Williams WV; Barjenbrach P; Adelstein E; Sharp GC; Walker SE
Arch Pathol Lab Med; 1986 Sep; 110(9):798-802. PubMed ID: 3530186
[TBL] [Abstract][Full Text] [Related]
9. Antinuclear antibodies in the investigation of rheumatic diseases.
Fritzler MJ
Bull Rheum Dis; 1985; 35(6):1-10. PubMed ID: 3879803
[No Abstract] [Full Text] [Related]
10. Influence of mitosis on the in vitro intra-nuclear penetration of anti-RNP antibodies in several cell and tissue cultures.
Guillet G; Fizet D; Guillet MH
Agressologie; 1986 Sep; 27(8):679-82. PubMed ID: 3548457
[No Abstract] [Full Text] [Related]
11. [Clinical significance of antinuclear antibodies in progressive systemic sclerosis].
Scagliusi P; De Lucia M; Di Luca ML; Pannarale M; Pipitone V
Minerva Med; 1984 Feb; 75(5):161-6. PubMed ID: 6366619
[TBL] [Abstract][Full Text] [Related]
12. [Detection of antibodies to extractable nuclear antigens with counterimmunoelectrophoresis and the Western blot technic].
Hauke G; Lührmann R; Metz B; Peter HH
Z Rheumatol; 1988; 47(1):26-9. PubMed ID: 3259356
[TBL] [Abstract][Full Text] [Related]
13. Comparison of substrates for the detection of antinuclear antibodies in normals and in patients with connective tissue and other diseases.
Lipscomb MF; Cope LD; Stephens GL; Deng JS; Gilliam JN
Diagn Immunol; 1984; 2(3):181-7. PubMed ID: 6388982
[TBL] [Abstract][Full Text] [Related]
14. [The clinical spectrum of patients with anticentromere antibodies].
Insua Vilariño S; de la Hera Martínez M; Rodríguez-Valverde V; Merino Pérez J; Alonso Valdivieso JL; Ruiz T
Rev Clin Esp; 1993 Apr; 192(6):260-4. PubMed ID: 8497719
[TBL] [Abstract][Full Text] [Related]
15. [Significance of anti-centromere antibodies. Clinical value].
Meyer O; Haim T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
[TBL] [Abstract][Full Text] [Related]
16. Differential isotype recognition of two centromere associated polypeptides by immunoblotting in connective tissue disease.
McHugh NJ; James IE; Maddison PJ
Clin Exp Immunol; 1988 Jun; 72(3):457-64. PubMed ID: 3048806
[TBL] [Abstract][Full Text] [Related]
17. [Connective tissue diseases and HEp-2 antinuclear antibodies].
Scagliusi P; Anelli P; Fasiello V; De Lucia M; Pipitone V
Minerva Med; 1985 May; 76(21):999-1003. PubMed ID: 3873632
[TBL] [Abstract][Full Text] [Related]
18. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
Diaz Gill GA; Beutner EH; Eisenberg RB
Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
[No Abstract] [Full Text] [Related]
19. [Detection of antinuclear antibodies using chicken erythrocytes in lupus erythematosus, scleroderma, rheumatoid arthritis and juvenile chronic arthritis].
Lucić N; Bosković B
Med Arh; 1985; 39(2-3):65-8. PubMed ID: 3917218
[No Abstract] [Full Text] [Related]
20. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
Zitnan D; Rovenský J; Cebecauer L; Hajzok O
Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583
[No Abstract] [Full Text] [Related]
[Next] [New Search]
